AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO 2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells
Artificial Cells, Nanomedicine, and Biotechnology · Available online 17 Jul 2026 · In press · DOI 10.1080/21691401.2026.2702868
Free full text
Authors (5)
Nikoo Baghal Darbandi, Zeinab Rostami Dehka, Mehrab Pourmadadi, Salar Mohammadi Shabestari, Elham Hatami Monfared
Abstract
This work reports the development and systematic evaluation of a carboxymethyl cellulose (CMC)-based nanocarrier system co-loaded with cerium oxide (CeO2) and carbon quantum dots (CQDs) for pH-responsive delivery of quercetin (QC) and in vitro evaluation in lung cancer cells. The nanocarriers were prepared using a water-in-oil-in-water (W/O/W) double emulsion approach, yielding spherical particles with an average size of approximately 134 nm and a high positive surface charge (+66 mV), indicative of favourable colloidal stability. FESEM analysis confirmed a uniform morphology and compact internal structure. The incorporation of CeO2 appears to reinforce the polymer matrix, contributing to improved drug encapsulation. The optimized formulation exhibited high encapsulation efficiency (88%) and drug loading capacity (47%), outperforming CeO2-free systems. In vitro release studies demonstrated a clear pH-dependent biphasic behaviour, with significantly faster release under pH 5.4 compared to physiological pH (7.4), reaching 98% and 58% after 96 h, respectively. Drug release followed the Higuchi model, suggesting diffusion-controlled kinetics, while the Korsmeyer–Peppas model indicated a non-Fickian mechanism. An AI-guided nonlinear modelling workflow was used to extract interpretable kinetic descriptors directly from experimental release data. Biological evaluation revealed enhanced anticancer activity against A549 cells, with viability reduced to 49.1%, while maintaining high biocompatibility towards L929 cells.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Darbandi, N., Dehka, Z., Pourmadadi, M., et al. (2026). AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO 2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells. Artificial Cells, Nanomedicine, and Biotechnology. https://doi.org/10.1080/21691401.2026.2702868
Related articles
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Antimicrobial properties and bioactivity of zirconia-based biocomposites · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Human tendon stem/progenitor cell-derived extracellular vesicle production promoted by dynamic culture · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Identification of mitophagy-related biomarkers in human rheumatoid arthritis using machine learning models · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Multi-omics analysis of the potential association between ageing and rheumatoid arthritis and screening of potential therapeutic targets · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Exosome-mediated perturbation of the immune-bone metabolism axis: a mechanistic investigation into bone loss in a simulated microgravity environment · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal